SEC Form 4 · accession 0001628280-26-047426
Cellebrite DI Ltd. · CLBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas E. Hogan
Officer — Chief Executive Officer · Director
Period of report
Jul 2, 2026
Accepted (ET)
Jul 7, 2026 · 7:29 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001854587
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary shares, par value NIS 0.00001F1,F2 | Jul 2, 2026 | S | 103,188 | $15.7566 | D | 590,777 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares reported as disposed herein were granted on September 19, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.44 to $15.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.